Method Development

Right‑fit analytical methods that secure stability data and simplify validation and transfer.

MEthod Development - Copy

METHODS BUILT FOR VALIDATION AND ROUTINE USE

We develop product-specific analytical chemistry and microbiological methods designed to support validation, stability testing, release, and ongoing quality control.

 

Analytical method development at Groupe PARIMA generates fit‑for‑purpose data to support product characterization, evaluate stability behavior, and inform development decisions with confidence.  

Methods are designed with a lifecycle perspective, ensuring suitability for ongoing stability studies as well as readiness for validation and seamless analytical transfer as development progresses.

Stage Ready Method Development

We connect chemistry and microbiology with stage-appropriate execution, so your data supports decisions on development, stability, and transfer.

Analytical Strategy Definition

We define the method’s intended use and performance targets (ATP) based on your product, matrix, and program stage, establishing clear acceptance criteria for development and validation. 

EARLY METHOD FEASIBILITY

We assess product knowledge, available reference methods, and product characteristics to define the analytical approach and required sensitivity. Early feasibility work focuses method development on conditions appropriate for the product.

Method Scouting and Optimization

We optimize existing methods by scouting standard conditions based on product properties and matrix, establishing a robust fit‑for‑purpose analytical starting point for development and validation.

Optimization for Validation

We refine critical method parameters to achieve consistent performance and target sensitivity. Parameters are evaluated and adjusted to ensure the method can reliably generate data under expected conditions.

Our quality by design approach strengthens method performance and supports regulatory confidence in your data.

Resources

Discover resources that help teams plan, develop, and transfer analytical methods with regulatory alignment in mind.

White papers
2026/07/06
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
White papers
2026/07/03
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Blog
2026/07/03
Topical 101: A Guide to Complex Dermatology Formulation Development
White papers
2026/07/06
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
White papers
2026/07/03
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Blog
2026/07/03
Topical 101: A Guide to Complex Dermatology Formulation Development

Contact Us

Have a project in pipeline?

Let’s discuss analytical method development and testing needs to support stability, development decisions, and stage-appropriate execution.